CWM
APD icon

Calamos Wealth Management’s Air Products & Chemicals APD Stock Holding History

Calamos Wealth Management’s Portfolio APD Stock Details APD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
944
+112
+13% +$32.6K 0.01% 389
2026
Q1 		$242K Buy
+832
New +$229K 0.01% 484
2025
Q4 		– Sell
-751
Closed -$205K – 472
2025
Q3 		$205K Buy
+751
New +$217K 0.01% 402
2025
Q1 		– Sell
-811
Closed -$235K – 333
2024
Q4 		$235K Buy
811
+14
+2% +$4.4K 0.01% 279
2024
Q3 		$237K Buy
797
+16
+2% +$4.38K 0.01% 282
2024
Q2 		$202K Buy
+781
New +$198K 0.01% 285
2024
Q1 		– Sell
-788
Closed -$216K – 316
2023
Q4 		$216K Sell
788
-465
-37% -$128K 0.01% 275
2023
Q3 		$355K Hold
1,253
– – 0.03% 234
2023
Q2 		$375K Buy
1,253
+8
+0.6% +$2.28K 0.03% 226
2023
Q1 		$358K Hold
1,245
– – 0.03% 238
2022
Q4 		$384K Hold
1,245
– – 0.03% 229
2022
Q3 		$290K Hold
1,245
– – 0.02% 256
2022
Q2 		$299K Sell
1,245
-48
-4% -$11.7K 0.03% 261
2022
Q1 		$323K Buy
1,293
+34
+3% +$8.74K 0.02% 277
2021
Q4 		$383K Sell
1,259
-37
-3% -$10.9K 0.03% 264
2021
Q3 		$332K Hold
1,296
– – 0.03% 269
2021
Q2 		$373K Buy
1,296
+521
+67% +$153K 0.03% 254
2021
Q1 		$218K Sell
775
-235
-23% -$63.9K 0.02% 284
2020
Q4 		$276K Sell
1,010
-47
-4% -$13.2K 0.03% 257
2020
Q3 		$315K Sell
1,057
-15,720
-94% -$4.52M 0.04% 225
2020
Q2 		$4.05M Sell
16,777
-1,913
-10% -$437K 0.51% 58
2020
Q1 		$3.73M Buy
18,690
+172
+0.9% +$39.2K 0.57% 50
2019
Q4 		$4.35M Sell
18,518
-2,316
-11% -$523K 0.51% 59
2019
Q3 		$4.62M Sell
20,834
-13,021
-38% -$2.93M 0.62% 46
2019
Q2 		$7.66M Buy
33,855
+312
+0.9% +$64.6K 1.03% 20
2019
Q1 		$6.41M Buy
33,543
+9,029
+37% +$1.55M 0.91% 26
2018
Q4 		$3.92M Buy
24,514
+6,612
+37% +$1.05M 0.59% 45
2018
Q3 		$2.99M Sell
17,902
-1,455
-8% -$237K 0.37% 66
2018
Q2 		$3.01M Buy
+19,357
New +$3.17M 0.38% 68

Other funds holding APD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Calamos Wealth Management's APD Position: Q2 2026 in Review

Calamos Wealth Management increased its Air Products & Chemicals (APD) stake by 13% in Q2 2026, buying an estimated $32.6K and bringing the position to 944 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #389.

Calamos Wealth Management first reported a position in APD in Q2 2018 and has held it in 29 quarters since. The position peaked at $7.66M in Q2 2019. 1,775 funds tracked by Wall St. Rank hold APD as of Q2 2026.

  • Calamos Wealth Management held 944 shares of Air Products & Chemicals worth $277K as of Q2 2026.
  • Calamos Wealth Management bought 112 Air Products & Chemicals shares in Q2 2026, an estimated $32.6K.
  • Air Products & Chemicals made up 0.01% of Calamos Wealth Management's portfolio in Q2 2026, its #389 holding.
  • Calamos Wealth Management first reported a position in Air Products & Chemicals in Q2 2018 and has held it in 29 quarters since.
  • Calamos Wealth Management's Air Products & Chemicals position peaked at $7.66M in Q2 2019.
  • 1,775 funds tracked by Wall St. Rank held Air Products & Chemicals as of Q2 2026.

Based on Calamos Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.